Background. The absolute renal risk (ARR) of dialysis/death in IgA nephropathy (IgAN) was based on three major, independent equipotent risk factors: hypertension, proteinuria ≥1 g/day and severe pathological score at diagnosis. We studied, in our prospective regional cohort of IgAN, the impact of body mass index (BMI) on the ultimate outcome in light of this ARR concept. Methods. We had information on 331 IgAN patients (233 men). At diagnosis, the BMI was normal (<25 kg/m
Background. The absolute renal risk (ARR) of dialysis/death in IgA nephropathy (IgAN) was based on three major, independent equipotent risk factors: hypertension, proteinuria ≥1 g/day and severe pathological score at diagnosis. We studied, in our prospective regional cohort of IgAN, the impact of body mass index (BMI) on the ultimate outcome in light of this ARR concept. Methods. We had information on 331 IgAN patients (233 men). At diagnosis, the BMI was normal (<25 kg/m 2 ) in 195 and elevated (≥25) in 136 (44.1%) with 102 overweight (25-29.9) and 34 obese (≥35) defining two groups, normal BMI and elevated BMI, subsequently compared. Results. At diagnosis, in the overweight/obese group, hypertension and proteinuria ≥1 g/day were more frequent (respectively, P < 0.0001 and P = 0.0006) and the mean global optical score was increased (P = 0.002). This resulted in a worse ARR scoring distribution (P < 0.0001). In addition, these patients with an elevated BMI were ∼10 years older (P < 0.0001), including more obese women and with an eGFR already lower (P = 0.0003). At last follow-up, in the overweight/obese group, progression remained worse with greater prevalence of CKD-3+ (43.4 versus 21.0%; P < 0.0001) and dialysis/death events (21.3 versus 13.9%). Kaplan-Meier survival and Cox regression analyses demonstrated that ARR remained a powerful independent risk factor for prediction of events, but not BMI. Conclusions. IgAN patients with an elevated BMI at diagnosis had a significantly worse presentation and worse final outcome. Overweight/obesity increased hypertension frequency, proteinuria level and some renal lesions all of which translate into a worse ARR for prediction of CKD-3+ or dialysis alone or dialysis/death, with no apparent direct effect of BMI per se.
I N T RO D U C T I O N

Body mass index (BMI) is the ratio of weight (kg) over squared height (m): W/H
2 and expressed in kg/m 2 . It remains a good parameter to appreciate excessive weight and the classification is as follows: low BMI (<18), normal BMI (18.00-24.99), overweight (25.00-29.99) and obesity (≥30.00) with Class 1 (30.00-34.99), Class 2 (35.00-39.99) and Class 3 (≥40, also called morbid obesity).
In 2001, we published [1] that overweight/obesity was a risk factor in the progression of IgA nephropathy (IgAN); it was associated with the early development of hypertension and at that time it appears to be independent of severe pathological lesions and of proteinuria in the progression to CKD-3+.
In 2011, we developed the absolute renal risk (ARR) concept [2] of progression to dialysis or death before dialysis (D/D) in 332 primary IgAN. This ARR scoring was based on the presence or absence of three major, independent and equipotent following risk factors at the time of diagnosis (by renal biopsy): arterial hypertension, proteinuria ≥1 g/day and severe histopathological lesions [our local global optical score (GOS) ≥8 with a range of 0-20, which is equivalent to Oxford MEST ≥2 with a range of 0-5]. The ARR score at diagnosis could be 0, 1, 2 or 3. This ARR scoring permitted us to accurately estimate the probability of reaching the combined event (D/D) at 20 years from the onset of the disease: 4% for ARR = 0; 9% for ARR = 1, 18% for ARR = 2 and 64% for ARR = 3, and also to estimate the probability of reaching D/D at 10 years post-diagnosis: 4% for ARR = 0; 8% for ARR = 1; 18% for ARR = 2 and 68% for ARR = 3.
The goal of this study was to revisit the exact impact of overweight/obesity [3] in a larger prospective cohort of primary IgAN focusing on these risk factors and in the light of this ARR new concept.
S U B J E C T S A N D M E T H O D S
Patients
We studied the patients of our prospective regional (SaintEtienne area) cohort of biopsy-proven IgAN (with at least 1+ mesangial deposits of IgA by immunofluorescence) with a biopsy performed within the 90-99 decade, the IGAN-STET-CO. We had complete information on 331 IgAN patients (233 men, 70.4%). Hypertension was defined according to the World Health Organization as blood pressure >140/90 at two different occasions or patients already under antihypertensive treatment. Twenty-four-hour proteinuria was measured and expressed in g/day or number of patients with proteinuria ≥1 g/day. The renal biopsy was scored according to our local classification [4, 5] : the GOS (range 0-20) is the sum of glomerular (0-6), vascular (0-5), tubular (0-4) and interstitial (0-5) indices; we previously showed by receiver operator curves that the best cut-off for dialysis prediction was GOS ≥8.
At the time of diagnosis, the presence of these three major, consensual, independent and equipotent risk factors was carefully checked and their number represented the ARR score: 0 if none was present, 3 if all were present and 1 or 2 if any one or two of these risk factors were present.
Methods
We defined two groups of patients according to the BMI value at diagnosis: normal versus elevated. We compared all clinical, histological parameters between these two groups at diagnosis and their outcome at last follow-up. The final primary outcome was composite dialysis or death, D/D event; the secondary outcome was occurrence of CKD-3+, defined as eGFR, calculated by abbreviated Modified Diet in Renal Diseases (MDRD) formula, below 60/mL/min/1.73 m 2 . We also carefully compared the distribution of these risk factors and the ARR score between these two groups: normal BMI versus elevated BMI (overweight/obesity).
Statistics
We compared quantitative data by an unpaired t-test and qualitative data by a contingency table. We also used Cox regression analysis (monovariate or multivariate) to test the exact impact of the different covariates; the endpoint was dialysis/death combined event or dialysis alone or CKD-3+; time zero was set up at the time of diagnosis preferentially to time of disease onset in order to reduce potential lead time bias. Kaplan-Meier survival curves (without the event) for the two groups were compared by the log-rank test and time zero was set up either at disease onset or at diagnosis.
R E S U LT S
The two groups: normal BMI versus elevated-BMI We found at diagnosis 195 IgAN patients with a normal BMI between 18.00 and 24.99 kg/m 2 and 136 with an elevated BMI of ≥25 kg/m 2 (41.1%) with 102 overweight (25.00-29.99) and only 34 obese (≥30). Gender distribution was not different: 61 women out of 195 (31.3%) versus 37 F/136 (27.2%; P = NS). However, there was an excess of obese patients among women (15/98 = 15.3%) versus men (19/ 233 = 8.2%; exact P = 0.08). The overweight/obese patients were ∼10 years older at diagnosis: 46.6 (13.6) versus 37.0 (14.0); t = −6.23; P < 0.0001, than patients with normal BMI, and also at disease onset ( Table 1) .
Distribution of the risk factors at diagnosis Hypertension
Hypertension was already present at disease onset in 13.8% (27/195) of normal-BMI patients compared with 33.8% in overweight/obese patients (46/136; χ 2 = 18.73; P < 0.0001). Hypertension at diagnosis was noted in 24.6% (48/195) of normal-BMI patients versus 52.9% of elevated BMI (72/136; χ 2 = 27.82; P < 0.0001) ( Table 1 ).
Proteinuria
The respective mean (SD) values in g/day were 0.68 (1.01) in normal-BMI patients versus 1.31 (1.74) in overweight/obese patients (t-test = −4.15; P < 0.0001). Proteinuria ≥1 g/day was observed in 22.1% of normal-BMI patients (43/195) compared with 39.7% in elevated-BMI patients (54/136; χ 2 = 12.05; P = 0.0003).
Pathological scoring
The respective mean (SD) GOS values in normal-BMI and in elevated-BMI were 6.49 (2.99) versus 7.57 (3.24) (t = −3.14; P = 0.002); 3.12 ( Table 2 ). Already at diagnosis, the renal function was worse in overweight/obese patients when compared with normal-BMI patients: the mean GFR was 69.1 (27.7) versus 80.2 (26.7) mL/ min/1.73 m 2 s (t = +3.67; P = 0.0003); GFR staging (1-5) was also worse (χ 2 = 14.17; P = 0.007); the percentage of patients in CKD-3+ was 33.8% (46/136) versus 17.9% (35/195; χ 2 = 10.92; exact P = 0.001).
Calculation of the ARR scoring at diagnosis in the two groups The ARR distribution was, respectively, for normal-and elevated-BMI groups as follows: ARR = 0 in 110 and 43 patients; ARR = 1 in 38 and 31; ARR = 2 in 28 and 35 and ARR = 3 in 19 and 27 (χ 2 = 22.42; P < 0.0001) ( Table 1) . 
Final endpoints
Downloaded from https://academic.oup.com/ndt/article-abstract/28/suppl_4/iv160/1847811 by guest on 06 March 2019 χ 2 = 18.99; P < 0.0001. The final eGFR was 59.3 (30.6) in overweight/obese versus 73.4 (31.5) in normal-BMI (t = + 4.06; P < 0.0001). The eGFR staging distribution was also significantly worse (χ 2 = 21.70; P = 0.0002) ( Table 3 ). The Kaplan-Meier survival curves (without dialysis/death event) stratified according to the ARR score was not different (log-rank test: P = NS) between the overweight/ obese and the normal-BMI groups, respectively, at 20 years from onset, 89 and 94% for ARR = 0; 88 and 87% for ARR = 1; 80 and 71% for ARR = 2 and 44 and 51% for ARR = 3. Similar data were found when time zero was set at diagnosis (Table 3) . 
O R I G I N A L A R T I C L E
F. Berthoux et al.
iv162 Gender, age, overweight/obesity (BMI ≥25), hypertension (HT), GOS ≥8, proteinuria ≥1 g/day, ARR score = 0, 1, 2, 3 and eGFR (mL/min/ 1.73 m 2 s). Note that time zero was set up at the time of diagnosis. Remember that the eGFR is part of the final endpoint and its use also as a covariate might not be recommended/optimal.
Cox multivariate regression with dialysis/death as endpoint and the following covariates: gender, BMI (dichotomous or continuous), ARR categories, age at diagnosis (continuous) and eGFR (continuous) confirmed that ARR scoring remained an independent and significant (P < 0.003) predictor (Table 4) . However, age at diagnosis also remained a significant risk factor independent from ARR scoring, while gender was not; younger age at diagnosis (and also at onset) was protective towards progression to dialysis/death.
At last follow-up, the distribution of BMI was as follows: 172 patients kept a normal BMI, but 23 changed the category: 13 became overweight (final number of 115) and 10 additional obese (final number of 44). At last follow-up, the different parameters of the metabolic syndrome [6] were as follows: 14.8% with fasting glucose ≥6.10 mmol/L; 9.4% with HbA1C ≥7.0%; 8.9% with diabetes; 25% with serum triglycerides ≥1.70 mmol/L; 22.0% with treated hypercholesterolaemia; and 30.3% with waist circumference ≥99 cm in women and 102 in men.
D I S C U S S I O N
We have demonstrated in this study that the BMI status at diagnosis (normal or elevated) was associated with a worse presentation at diagnosis in the overweight/obese IgAN patient group: more patients with hypertension; more patients with proteinuria ≥1 g/day; and a trend for more severe renal pathology (borderline). Consequently, the ARR score for dialysis/ death was also significantly worse in this group compared with the normal-BMI group. As expected, the final outcome was globally worse in the overweight/obese IgAN group: lower final GFR, more patients in CKD-3+ and more patients ending to dialysis or death.
The effect of BMI (used either as a continuous or dichotomous covariate) was neither significant nor independent. Both gender and age at diagnosis impacted the distribution of the ARR scoring: worse in men and worse in older patients at presentation [2] . The multivariate Cox regression analyses including these additional parameters confirmed that age at diagnosis plays an additional and independent role on the top of either the three risk factors (hypertension, proteinuria≥1 g/day and GOS ≥8) or the ARR score; however, with a lower magnitude. Younger age at diagnosis (and also at disease onset) was associated with a better final outcome both by indirect (lower ARR scoring) and direct favourable effects. In order to reduce the association between overweight/obesity and older age, we have restricted the analysis to a subgroup of patients aged between 35 and 54.9 years at diagnosis (147 patients with 87 in the normal-BMI and 60 in the elevated-BMI groups): BMI ≥ 25 also had no direct effect per se on the ultimate outcome. Note that the inclusion of renal function at diagnosis (eGFR continuous, or CKD staging, or CKD-3+ dichotomous) as a covariate is questionable, because it is, in some way, already part of the final endpoint, raising the appropriateness of using the same parameter both as a covariate and as an endpoint in the same analysis! The next question is how elevated BMI translates into more risk factors (hypertension, proteinuria and severe renal lesions). The vascular/arteriolar lesions inside the kidney (renal biopsy) were greater in the overweight/obese group, and this was probably associated with the subsequent development of arterial hypertension. Increased proteinuria in the same group was probably linked to more tubular and interstitial lesions together with more obsolescent glomeruli and a trend to more crescentic glomeruli. Surprisingly, the percentage of glomeruli with FSGS was not different among the two groups and among the obese and overweight subgroups; this could be explained by the small number of very obese patients in this study. This type of lesion is usually associated with morbid obesity (BMI ≥ 30 kg/m 2 ). Additional specific ultrastructural studies [7, 8] demonstrated a larger glomerular diameter and a greater glomerular area in obese IgAN patients compared with others, indicating a glomerulomegaly [9] .
We are also confirming and extending our previous results [1] : increased BMI associated with more precocious hypertension and its consequences on final outcomes (CKD-3+, dialysis and death). Finally, in the literature, there are a very few studies [1, [6] [7] [8] on this specific subject in IgAN; our present study is the most extensive.
CO N C L U S I O N S
In IgAN, overweight/obesity, present at diagnosis, was associated with an increase in the major risk factors (more hypertension, more proteinuria and more severe renal lesions) which translate into a worse ARR resulting in more CKD-3+ and more dialysis/death events.
CO N F L I C T O F I N T E R E S T S TAT E M E N T
None declared. Part of this study was published in 2001 [1] .
R E F E R E N C E S A B S T R AC T
Background. Obesity has risen considerably in the Western world and the trend is increasing in non-Western, developing countries, as well. Several school screening studies showed the relation between body mass index and hypertension. In adults, obesity is associated with an increased risk of development and progression of kidney disease. However, data at the epidemiological level are limited, both for children and adults. The aim of this study was to determine the prevalence of obesity and evaluate its association with hypertension and glomerular filtration rate (GFR) among children in Turkey. Methods. A population-based field study in which individuals were accessed by house visits throughout Turkey has been conducted. The study sample (3622 children; 5-18 years; 49.6% female, mean age 11.88 ± 3.40 years) was selected to represent the Turkish population regarding geographical region, gender and age (5-18 years). Obesity was defined as the body mass index ≥95th percentile for age and gender. The Schwartz formula was used to estimate GFR. Blood pressure (BP) percentile was determined according to age, gender and length. Results. The prevalence of overweight, obesity and hypertension were 9.3, 8.9 and 6.1%, respectively. Logistic regression analysis revealed urban area (OR 1.50; 95% CI 1.15-1.96; P = 0.003) as an independent risk for obesity and age decreased (OR 0.921; 95% CI 0.890-0.924; P < 0.001) risk for obesity. Obese children had the highest rate of hypertension (11.4 versus 5.6%; P < 0.001; OR 2.17, 95% CI 1.49-3.17; P < 0.001) and stage II hypertension (3.8 versus 0.7%; OR 6.01, 95% CI 2.93-12.33; P < 0.001). Systolic and diastolic BP z-scores were significantly higher in obese children. The mean estimated (eGFR) was lower in obese children (122.7 ± 21.6 versus 129.4 ± 23.1, P < 0.001). The rates of children with eGFR < 90 and <75 mL/min/1.73 m 2 were higher in obese patients, but did not reach statistical significance. Conclusions. Our nation-wide population-based field study among children showed that the prevalence of obesity is increasing in Turkey. The prevalence of hypertension and stage II hypertension, BP z-scores and eGFR were associated
